Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Updated: J&J’s third talc bankruptcy bid is stopped by Texas federal judge
2 months ago
Law
Federal judge nixes FDA's lab-developed test rule, says it exceeded agency's authority
2 months ago
Law
DC court sides with HHS in Vertex's fertility program fight
2 months ago
Cell/Gene Tx
Law
Merck’s PAH drug cuts risk of serious events by 76% in trial stopped for efficacy
2 months ago
R&D
Lykos’ interim CEO is set to step down
2 months ago
R&D
Judge tosses Amgen's challenge to Colorado drug review board, says suit is 'too speculative'
2 months ago
Law
J&J beats Viatris in patent fight over its antipsychotic drug, staving off competition
2 months ago
Law
CHMP recommends seven label expansions and one new approval, rejects Lilly Alzheimer's drug
2 months ago
FDA+
Milestone's shares dive after FDA again rejects drug for abnormal heart rhythm
2 months ago
Manufacturing
European regulator rejects Lilly's Alzheimer’s drug over potentially fatal side effects
2 months ago
FDA+
Novo inks second obesity deal of the week, with Lexicon oral drug partnership worth up to $1B
2 months ago
Deals
Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025
2 months ago
Startups
With tariffs on the way, generic drugmaking woes could hinder Trump’s reshoring plan
2 months ago
Manufacturing
Kennedy announces 10,000 job cuts at HHS, with major reductions expected at FDA, NIH and CDC
2 months ago
FDA+
Exelixis’ primary cancer drug wins FDA approval for neuroendocrine tumors
2 months ago
R&D
Small biotech joins list of health companies taking a trip to Trump's Mar-a-Lago
2 months ago
R&D
J&J touts new survival data pitting lung cancer combo against AstraZeneca's rival
2 months ago
R&D
Marketing
Trump tariffs would increase costs for almost every biopharma company, survey claims
2 months ago
Senate confirms Makary as FDA chief with agency cuts, return-to-office in force
2 months ago
R&D
FDA+
Eisai cuts Leqembi 2027 sales forecast by half but expects 'continued growth'
2 months ago
Senate committee backs Dr. Oz's nomination to lead CMS
2 months ago
People
Axsome reports Phase 3 win for Sunosi in adults with ADHD, with a high-dose caveat
2 months ago
R&D
GSK scores FDA approval for antibiotic to treat uncomplicated UTIs
2 months ago
FDA+
Merck strikes deal for heart drug, worth up to $2B, with China’s Hengrui
2 months ago
Deals
China
First page
Previous page
8
9
10
11
12
13
14
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit